Bacteraemia among patients attending a cancer hospital in Lahore, Pakistan

British Journal of Biomedical Science

Volumn 57, Issue 2, 2000, Pages 119-125

  Mortlock, Stephen ^a,b  

^a SHAUKAT KHANUM MEMORIAL CANCER HOSPITAL AND RESEARCH CENTRE   (Pakistan)

^b QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

Author keywords

Bacteremia; Fever of unknown origin; Immunocompromised host

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BACTEREMIA; BLOOD CULTURE; CANCER CENTER; CHILD; COAGULASE NEGATIVE STAPHYLOCOCCUS; CULTURE MEDIUM; ENTEROBACTERIACEAE; ESCHERICHIA COLI; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PAKISTAN; PRESCHOOL CHILD; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SCHOOL CHILD; STAPHYLOCOCCUS AUREUS;

ADOLESCENT; ADULT; BACTEREMIA; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; INFANT; MALE; MIDDLE AGED; NEOPLASMS; OPPORTUNISTIC INFECTIONS;

ENTEROBACTERIACEAE; ESCHERICHIA COLI; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCI; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 0034084863     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Bodey GP, Bolivar R, Fainstein V. Infectious complications in leukaemic patients. Semin Haematol 1982; 19:193-226.
2. Bodey GP. Antibiotics in patients with neutropenia. Arch Intern Med 1984; 44:1845-54.
3. Schimpff SC, Young VM, Greene WH et al. Origin of infection in acute lymphocytic leukaemia: significance of hospital acquisition of potential pathogens. Arch Intern Med 1972; 77:707-14.
4. Klastersky J, Zinner SH. Synergistic combination of antibiotics in Gram-negative bacillary infections. Rev Infect Dis 1982; 4:294-301.
5. Sulier JP, Klastersky J. Significance of serum bacteriocidal activity in Gram-negative bacillary bacteraemia in patients with and without granulocytopenia. Am J Med 1984; 76:429-35.
6. EROTC International Antimicrobial Therapy Co-operative Group. Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. J Infect Dis 1978; 137:14-29.
7. EORTC International Antimicrobial Therapy Co-operative Group. Ceftazidime combined with a short course of amikacin for empirical therapy of Gram-negative bacteraemia in cancer patients with granulocytopenia. N Engl J Med 1987; 317:1692-9.
8. EORTC International Antimicrobial Therapy Co-operative Group. Combination of amikacin and carbenicillin with or without cefazolin as empirical treatment of febrile neutropenic patients. J Clin Oncol 1983; 1:597-603.
9. Klastersky J, Glauser MP, Schimpff SC et al. Prospective randomised comparison of three antibiotic regimens for empirical therapy of suspected bacteraemia infection in febrile granulocytopenic patients. Antimicrob Agents Chemother 1986; 29:263-70.
10. EORTC International Antimicrobial Therapy Co-operative Group. Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. J Infect Dis 1991; 163:951-8.
11. EORTC International Antimicrobial Therapy Co-operative Group. Single versus multiple daily doses of amikacin combined with ceftriaxone or ceftazidime for the treatment of fever in granulocytopenic cancer patients. Ann Intern Med 1993; 119:584-93.
12. The GIMEMA Infection Program. Prevention of bacterial infection in neutropenic patients with haematological malignancies. A randomised multicentre trial comparing norfloxacin with ciprofloxacin. Ann Intern Med 1991; 115:7-12.
13. Reimer LG, Wilson ML, Weinstein MP. Update on the detection of bacteraemia and fungaemia. Clin Microbiol Rev 1997; 10:444-65.
14. Weinsteim MP, Towns ML, Quartey SM et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteraemia and fungaemia in adults. Clin Infect Dis 1997; 24:584-602.
15. Wade JC. Antibiotic therapy for the febrile granulocytopenic cancer patient: combination therapy vs monotherapy. J Infect Dis 1989; 11:S1572-81.
16. Darbyshire PJ, Williamson PJ, Pedler SJ et al. Ceftazidime in the treatment of febrile immunosuppressed children. J Antimicrob Chemother 1993; 12:357-60.
17. Fainstein V, Bodey GP, Elting L et al. A randomised study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infection in cancer patients. J Antimicrob Chemother 1993; 12:101-10.
18. Verlagen CS, de Pauw B, de Witte T et al. Randomised prospective study of ceftazidime versus ceftazidime plus cephalothin in empiric treatment of febrile episodes in severely neutropenic patients. Antimicrob Agents Chemother 1987; 31:191-6.
19. World Health Organisation. Antimicrobial Resistance. Geneva: WHO Scientific Working Group, 1981.
20. Jackson FL. Antibiotic resistance. Int Med 1981; 3:101.
21. Hafeez A. Hospital-and community-acquired MRSA. Inf Dis J Pak 1996; 3:12-3.
22. Tasnim A. Antimicrobial therapy in typhoid fever. Inf Dis J Pak 1996; 3:21.
23. Sultan F. Fever and neutropenia - a brief review. Inf Dis J Pak 1997; 4:6-7.
24. Bauer AN, Kirby WMM, Sherris JC, Tuck M. Antibiotic susceptibility testing by a standardised single disc method. Am J Clin Pathol 1996; 45:493-6.
25. National Committee for Clinical Laboratory Standards. Performance standards for the antimicrobial disc susceptibility test. National Committee for Clinical Laboratory Standards, 4the Edition. M2-T4. PA, USA: Villanova, 1988.
26. Lyytikäinen O, Valtonen V, Antilla V-J, Ruutu P. Evaluation of clinical and laboratory findings in leukaemic patients with blood cultures positive for Staphylococcus epidermidis. J Hosp Inf 1998; 38:27-5.
27. Grosserode MH, Wenzel RP. The continuing importance of staphylococci as major hospital pathogens. J Hosp Inf 1991; 19:B3-17.
28. Souvenir D, Anderson DE Jr, Palpart S et al. Blood cultures positive for coagulase-negative staphylococci: antisepsis, pseudobacteraemia and therapy of patients. J Clin Microbiol 1998; 36:1923-6.
29. Wolf MS, Armstrong D, Louria DB, Blevins A. Salmonellosis in patients with neopalstic disease: a review of 100 episodes at Memorial Cancer Center over a 13-vear period. Arch Intern Med 1971; 128:546-53.
30. Beebe JL, Koneman EW. Recovery of uncommon bacteria from blood: association with neoplastic disease. Microbiol Rev 1995; 8:336-56.
31. Hseueh P-R, Teng L-J, Yang P-C et al. Nosocomial infections caused by Sphingomonas paucimobilis: clinical features and microbiological characteristics. Clin Inf Dis 1998; 26:676-81.
32. Brink AJ, van Straken A, van Rensburg AJ. Shewenella (Pseudomonas) putrefaciens bacteraemia. Clin Inf Dis 1995; 20:1327-32.
33. Ioannides JPA, Worthington M, Griffiths JK, Snydman DR. Spectrum and significance of bacteraemia due to Moraxella catarrhalis. Clin Inf Dis 1995; 21:390-7.
34. Sultan F, Mortlock S, Usmani GN, Rana I, Ashraf S. Candidaemia in cancer patients: an experience over 23 months [Abstract]. In: Program and Abstracts: Third Shaukat Khanum Memorial Hospital Cancer Symposium, Lahore, Pakistan, February 1997.
35. Mortlock S. In vitro activities of imipenem and meropenem against organisms isolated from clinical specimens. Inf Dis J Pak 1997; 4:8.
36. Sultan F, Rose S, Mortlock S et al. Bacteraemia in a cancer hospital in Pakistan [Abstract]. In: Program and Abstracts: Third Shaukat Khanum Memorial Hospital Cancer Symposium, Lahore, Pakistan, February 1997.
37. Mortlock S. In vitro activities of gentamicin and tobramycin against clinical isolates. Inf Dis J Pak 1997; 4:20-1.
38. Gillespie T and Masterton RG. Investigation of infection in the neutropenic patient with fever. J Hosp Inf 1998; 38:77-91.
39. Zaidi AK, Knaut AL, Mirrett S et al. Value of routine anaerobic blood cultures for paediatric patients. J Paediatr 1995; 127:263-8.